The packaging mistakes that quietly delay MedTech launches

Ten reasons sterile packaging validation fails, and how to avoid each one.

Pack­ag­ing is often the last thing any­one wor­ries about, and the first thing that stalls a launch. When a ster­ile bar­ri­er fails val­i­da­tion, the whole time­line slips. Below are the ten fail­ure modes we see most often in ster­ile pack­ag­ing val­i­da­tion, and the con­crete step that pre­vents each one. Every check is one we run in our ISO/IEC 17025-accred­it­ed lab.

1. Incon­sis­tent or out-of-spec seals

The seal­ing process was nev­er prop­er­ly qual­i­fied (OQ/PQ), so seal strength drifts over time. Qual­i­fy the process win­dow and mon­i­tor seal strength (ASTM F88) so every pack per­forms the same.

2. Chan­nel leaks and seal defects go undetected

Time-zero inspec­tion miss­es small chan­nels. Add accred­it­ed integri­ty test­ing: dye pen­e­tra­tion (ASTM F1929 for porous, ASTM F3039 for non-porous), bub­ble emis­sion (ASTM F2096 / D3078) and visu­al seam inspec­tion (ASTM F1886).

3. Mate­r­i­al and ster­il­iza­tion method do not match

The bar­ri­er degrades under the ster­il­iza­tion modal­i­ty. For gam­ma or X‑ray irra­di­a­tion, con­firm mate­r­i­al com­pat­i­bil­i­ty and val­i­date the bar­ri­er before release.

4. Shelf-life claims rest on aging assump­tions alone

Accel­er­at­ed aging (ASTM F1980) used with­out a real-time con­fir­ma­tion plan is not defen­si­ble. Run both accel­er­at­ed and real-time aging so the two con­firm each other.

5. The dis­tri­b­u­tion pro­file is not representative

A trans­port sim­u­la­tion that does not match the real sup­ply chain (ASTM D4169 or ISTA 3) lets field dam­age appear that test­ing nev­er pre­dict­ed. Choose the pro­file that reflects actu­al dis­tri­b­u­tion, and add cli­mate test­ing (ASTM D4332) where relevant.

6. Integri­ty is only test­ed at time zero

If pack­age integri­ty is not re-test­ed after aging and dis­tri­b­u­tion, late fail­ures slip through. Test integri­ty after the stress, not just before.

7. Sharp or heavy devices breach the barrier

Ortho­pe­dic and spine implants punc­ture or abrade stan­dard pouch­es. Match the pack­ag­ing design to the device, and ver­i­fy punc­ture resis­tance (ASTM F1306 / EN 14477) and seal strength (ASTM F88) on the actu­al pack.

8. Asep­tic pre­sen­ta­tion is not validated

A bar­ri­er that will not open clean­ly in the OR risks con­t­a­m­i­na­tion at the point of use. Val­i­date peel and pre­sen­ta­tion, not just the seal.

9. Doc­u­men­ta­tion and trace­abil­i­ty gaps

Incom­plete or untrace­able IQ/OQ/PQ pro­to­cols stall the 510(k) or tech­ni­cal file. Build the doc­u­men­ta­tion trail from the start.

10. Changes are not re-validated

A mate­r­i­al, sup­pli­er or process change that slips through with­out change con­trol inval­i­dates the orig­i­nal evi­dence. Tie every change to a re-val­i­da­tion decision.

Trust

Further information or consulting

Need check or consulting of your validation process? Talk to us.

See how we put these checks into practice, in an accredited lab.

Explore our validation services